Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB–mediated induction of the Ets transcription factor ESE‐1

Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells... Objective To investigate the expression of the novel Ets transcription factor ESE‐1 in rheumatoid synovium and in cells derived from joint tissues, and to analyze the role of nuclear factor κB (NF‐κB) as one of the central downstream targets in mediating the induction of ESE‐1 by proinflammatory cytokines. Methods ESE‐1 protein expression was analyzed by immunohistochemistry using antibodies in synovial tissues from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). ESE‐1 messenger RNA (mRNA) levels were analyzed by reverse transcriptase–polymerase chain reaction or Northern blotting in human chondrocytes, synovial fibroblasts, osteoblasts, and macrophages, before and after exposure to interleukin‐1β (IL‐1β), tumor necrosis factor α (TNFα), or lipopolysaccharide (LPS) with or without prior infection with an adenovirus encoding the inhibitor of nuclear factor κB (IκB). The wild‐type ESE‐1 promoter and the ESE‐1 promoter mutated in the NF‐κB site were cloned into a luciferase reporter vector and analyzed in transient transfections. Electrophoretic mobility shift assays (EMSAs) and supershift assays with antibodies against members of the NF‐κB family were conducted using the NF‐κB site from the ESE‐1 promoter as a probe. Results Immunohistochemical analysis showed specific expression of ESE‐1 in cells of the synovial lining layer and in some mononuclear and endothelial cells in RA and OA synovial tissues. ESE‐1 mRNA expression could be induced by IL‐1β and TNFα in cells such as synovial fibroblasts, chondrocytes, osteoblasts, and monocytes. Transient transfection experiments and EMSAs showed that induction of ESE‐1 gene expression by IL‐1β requires activation of NF‐κB and binding of p50 and p65 family members to the NF‐κB site in the ESE‐1 promoter. Overexpression of IκB using an adenoviral vector blocked IL‐1β–induced ESE‐1 mRNA expression. Chromatin immunoprecipitation further confirmed that NF‐κB binds to the ESE‐1 promoter in vivo. Conclusion ESE‐1 is expressed in synovial tissues in RA and, to a variable extent, in OA, and is specifically induced in synovial fibroblasts, chondrocytes, osteoblasts, and monocyte/macrophages by IL‐1β, TNFα, or LPS. This induction relies on the translocation of the NF‐κB family members p50 and p65 to the nucleus and transactivation of the ESE‐1 promoter via a high‐affinity NF‐κB binding site. ESE‐1 may play a role in mediating some effects of proinflammatory stimuli in cells at sites of inflammation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatism Wiley

Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB–mediated induction of the Ets transcription factor ESE‐1

Download PDF
12 pages

Loading next page...
 
/lp/wiley/responses-to-the-proinflammatory-cytokines-interleukin-1-and-tumor-LFCEa6MQMK

References (54)

Publisher
Wiley
Copyright
Copyright © 2003 by the American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/art.10942
pmid
12746898
Publisher site
See Article on Publisher Site

Abstract

Objective To investigate the expression of the novel Ets transcription factor ESE‐1 in rheumatoid synovium and in cells derived from joint tissues, and to analyze the role of nuclear factor κB (NF‐κB) as one of the central downstream targets in mediating the induction of ESE‐1 by proinflammatory cytokines. Methods ESE‐1 protein expression was analyzed by immunohistochemistry using antibodies in synovial tissues from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). ESE‐1 messenger RNA (mRNA) levels were analyzed by reverse transcriptase–polymerase chain reaction or Northern blotting in human chondrocytes, synovial fibroblasts, osteoblasts, and macrophages, before and after exposure to interleukin‐1β (IL‐1β), tumor necrosis factor α (TNFα), or lipopolysaccharide (LPS) with or without prior infection with an adenovirus encoding the inhibitor of nuclear factor κB (IκB). The wild‐type ESE‐1 promoter and the ESE‐1 promoter mutated in the NF‐κB site were cloned into a luciferase reporter vector and analyzed in transient transfections. Electrophoretic mobility shift assays (EMSAs) and supershift assays with antibodies against members of the NF‐κB family were conducted using the NF‐κB site from the ESE‐1 promoter as a probe. Results Immunohistochemical analysis showed specific expression of ESE‐1 in cells of the synovial lining layer and in some mononuclear and endothelial cells in RA and OA synovial tissues. ESE‐1 mRNA expression could be induced by IL‐1β and TNFα in cells such as synovial fibroblasts, chondrocytes, osteoblasts, and monocytes. Transient transfection experiments and EMSAs showed that induction of ESE‐1 gene expression by IL‐1β requires activation of NF‐κB and binding of p50 and p65 family members to the NF‐κB site in the ESE‐1 promoter. Overexpression of IκB using an adenoviral vector blocked IL‐1β–induced ESE‐1 mRNA expression. Chromatin immunoprecipitation further confirmed that NF‐κB binds to the ESE‐1 promoter in vivo. Conclusion ESE‐1 is expressed in synovial tissues in RA and, to a variable extent, in OA, and is specifically induced in synovial fibroblasts, chondrocytes, osteoblasts, and monocyte/macrophages by IL‐1β, TNFα, or LPS. This induction relies on the translocation of the NF‐κB family members p50 and p65 to the nucleus and transactivation of the ESE‐1 promoter via a high‐affinity NF‐κB binding site. ESE‐1 may play a role in mediating some effects of proinflammatory stimuli in cells at sites of inflammation.

Journal

Arthritis & Rheumatism – Wiley

Published: May 1, 2003

There are no references for this article.